Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Importance of the field: Chronic obstructive pulmonary disease (COPD) is a disease
characterized by chronic airflow obstruction and a progressive lung function decline …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …

Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease
(COPD). Since inflammatory processes play a key role in the pathogenesis of the disease …

The use of inhaled corticosteroids (ICSs) in long-term treatment of COPD has been a
debated topic for a long time. According to the evidence produced till now, ICSs are …

Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

Introduction: Current guidelines recommend the use of inhaled long-acting bronchodilators,
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …